Table 1

Hill equation parameter estimates for the in vivo effects of CPA analogs and R-PIA on heart rate in the rat

α1-anHpEC50
CPA205  ± 17.40.89  ± 0.298.45  ± 0.16
(1600)(0.06)(0.08)
2′dCPA63  ± 12.21.31  ± 0.175.59  ± 0.05
(930)(0.62)(0.09)
3′dCPA161  ± 14.41.09  ± 0.146.95  ± 0.09
(1282)(0.09)(0.04)
5′dCPA273  ± 18.91.18  ± 0.047.30  ± 0.02
(1920)(0.89)(0.11)
8MCPA130  ± 13.91.03  ± 0.146.39  ± 0.13
(1018)(0.64)(0.05)
8ECPA123  ± 21.90.89  ± 0.125.97  ± 0.01
(2938)(0.16)(0.00)
8PCPA111  ± 22.51.72  ± 0.416.40  ± 0.03
(1011)(0.90)(0.08)
8BCPA54  ± 7.64.44  ± 0.576.15  ± 0.02
(168)(92.4)(0.06)
8CPCPA1-b 1-b 1-b
R-PIA181  ± 21.52.26  ± 0.647.26  ± 0.04
(2000)(2.58)(0.04)

Parameter estimates (mean ± S.E, n = 6–7) for upper asymptote (α), Hill slope (nH) and midpoint location (pEC50) were obtained by nonlinear mixed-effect modeling as described under “Methods.” The variances (ω2) describing the interindividual parameter variation are shown in parentheses.

  • 1-a Beats per minute.

  • 1-b No significant effect.